Association between dietary magnesium intake and pelvic inflammatory disease in US women: a cross-sectional study of NHANES

Background: Pelvic inflammatory disease (PID) is a common gynecological condition associated with significant morbidity and healthcare costs. Emerging evidence suggests that dietary factors, such as magnesium intake, may play a role in PID risk. However, the relationship between dietary magnesium intake and PID risk remains uncertain. This cross-sectional study aimed to investigate the association between dietary magnesium intake and the risk of PID.

Methods: This cross-sectional study included data from the National Health and Nutrition Examination Survey (NHANES) 2015–2018. Weighted multivariable logistic regression was used to examine the association between dietary magnesium intake and PID. Restricted cubic spline (RCS) analysis was performed to assess the linear and non-linear associations. Subgroup analyses were performed based on baseline characteristics.

Results: A total of 3,034 women aged 20–59 were included in the study. Magnesium intake exhibited a significant association with lower PID risk in weighted multivariable logistic regression. Adjusted odds ratios (ORs) for dietary magnesium intake in quartiles Q2 (133.12–214.93 mg/day), Q3 (214.93–287.19 mg/day), and Q4 (above 287.19 mg/day) compared to Q1 (below 133.12 mg/day) were 0.48 (95% CI: 0.28–0.82), 0.64 (95% CI: 0.32–1.27), and 0.40 (95% CI: 0.18–0.88), respectively. Stratified analyses showed that significant association between dietary magnesium intake and PID in older subgroup but not in younger subgroup. Additionally, RCS analyses consistently revealed a linear negative correlation between dietary magnesium intake and PID risk.

Conclusion: This study reveals a significant negative correlation between dietary magnesium intake and risk of PID, particularly among older individuals. These findings underscore the importance of dietary factors in gynecological health and highlight the potential role of magnesium supplementation in PID prevention strategies.

1 Introduction

Pelvic Inflammatory Disease (PID) is a commonly encountered inflammatory ailment, primarily affecting sexually active young females. It is characterized by infections in the upper reproductive system, specifically targeting the uterus, fallopian tubes, ovaries, and pelvic peritoneum (1). Without prompt treatment, PID harbors the potential to culminate in dire consequences, including ectopic pregnancy, infertility, persistent pelvic pain, and adverse pregnancy outcomes (2). Despite its high incidence, PID can be prevented and managed through lifestyle modifications, including dietary changes (3, 4).

Magnesium, a vital element abundantly present in daily meals, is crucial for DNA and RNA synthesis, cell growth, and protein production, ranking as the human body’s fourth most important mineral (5, 6). Research indicates that the dietary magnesium intake in developed countries has declined over recent decades due to the increased consumption of processed and fast foods (7). This trend has particularly impacted the United States, where most adults, especially young girls and women, fall short of reaching the recommended daily intake of magnesium (8–10). Insufficient magnesium intake is associated with a series of chronic conditions, including cardiovascular diseases, type 2 diabetes mellitus, osteoporosis, lung diseases, depression, migraines, and inflammatory diseases (11). Intriguingly, an inverse correlation exists between the intake of dietary magnesium and the levels of serum C-reactive protein (CRP) (12–14). However, the connection between the consumption of dietary magnesium and the incidence of PID remains to be established.

In this study, we analyzed data from the National Health and Nutrition Examination Survey (NHANES) (2015–2018) to uncover the relationship between the intake of dietary magnesium and the likelihood of developing PID. Our study may provide new insights for the prevention and clinical management of PID.

2 Materials and methods

2.1 Data source and participants

This study utilized a cross-sectional research approach, utilizing data from the NHANES, a comprehensive, multistage, stratified, and complex survey conducted nationally by the Centers for Disease Control and Prevention (CDC). Participants underwent initial interviews in their homes, followed by a series of clinical and laboratory tests at Mobile Examination Centers (MEC). Detailed information about the survey and associated research data is available on the NHANES website at https://www.cdc.gov/nchs/nhanes/.

The study selected participant data from two NHANES survey cycles (2015–2016 and 2017–2018). Initially, 19,225 female participants were included. In the second step, 15,720 samples lacking PID data were excluded. In the third step, 168 samples with missing dietary magnesium data were excluded. Additionally, 303 participants with missing demographic information, hypertension data, and smoking data were considered ineligible. Ultimately, a total of 3,034 women aged 20–59 were included in our final analysis, of which 183 had PID. Additionally, our study employed weighted adjustments to accurately reflect the demographic composition of the United States population. The flowchart detailing the inclusion and exclusion criteria is shown in Figure 1.

Figure 1

Figure 1. Flowchart of participant selection from NHANES 2015–2018.

The NHANES initiative received ethical clearance from the Ethical Review Committee of the National Center for Health Statistics, with all participants providing written informed consent. Our study rigorously adhered to the protocols outlined by the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) criteria (15).

2.2 Assessment of dietary magnesium intake

The NHANES study utilized a 24-h dietary recall questionnaire, administered to all study participants. This questionnaire collected comprehensive information on all foods and beverages consumed in the past 24 h, detailing the types and quantities of each item (16). For each NHANES participant from the 2015–2018 cycles, two 24-h recalls were conducted. The first dietary recall was performed at the NHANES Mobile Examination Center (MEC), and the second recall was conducted by trained interviewers via telephone 3–10 days after the MEC interview. We calculated the average dietary magnesium intake from the two recall periods; if the second recall was unavailable, the data from the first recall was used. To accurately estimate the dietary magnesium consumption, the Food Intake Analysis System developed by the University of Texas was used, in conjunction with the USDA’s National Nutrient Database for Standard Reference.

2.3 Assessment of pelvic inflammatory disease

The diagnosis of PID was assessed using data obtained from the NHANES Reproductive Health questionnaire. Specifically, question RHQ078 asked: “Have you ever been treated for an infection in your fallopian tubes, uterus, or ovaries, also called a pelvic infection, pelvic inflammatory disease, or PID?” Participants who answered “Yes” to this question were considered to have PID.

2.4 Covariates

Consistent with previous pertinent research (4, 16–18), demographic factors (age, race, educational background, marital status), socioeconomic status [Poverty Income Ratio (PIR)], health and lifestyle indicators [Body Mass Index (BMI), smoke status, presence of chronic conditions such as diabetes and hypertension], and reproductive health metrics (regularity of menstrual periods) were included as covariates in our analysis. Age was classified into two groups: 20–40 years and 41–59 years. Race was classified into four categories: Non-Hispanic White, Mexican American, Non-Hispanic Black, and other races. Meanwhile, educational background was organized into three tiers: below high school, high school, and above high school (19). Marital status was categorized as married or living with a partner or living alone (20). NHANES meticulously recorded participants’ smoking behaviors, including status, duration, and associated activities (21). Smoking status was categorized as follows (22): never smokers are adults who have not smoked or have smoked less than 100 cigarettes in total; former smokers have smoked 100 or more cigarettes but no longer smoke; current smokers have smoked over 100 cigarettes and continue to smoke, whether occasionally or daily. For the evaluation of diabetes, participants were asked, “Have you ever been told by a doctor or health professional that you have diabetes or sugar diabetes?” Respondents affirming this question were classified as diabetic (23). Hypertension was diagnosed by averaging three measurements of resting brachial arterial pressure, with the criteria being a systolic pressure of 140 mmHg or higher and a diastolic pressure of 90 mmHg or higher (24). The PIR compares household income to the poverty line, indicating socioeconomic status. Categories include low (PIR under 1.35), middle (PIR 1.35–3.0), and high (PIR over 3.0) (25, 26). BMI is classified into normal weight (below 25.0 kg/m²), overweight (25.0–29.9 kg/m²), and obesity (above 30.0 kg/m²) (27). Regular period data were assessed through the reproductive health questionnaire that asked, “Had regular periods in past 12 months (eligible for participants aged 12 years older)?,” and women who were pregnant or who had bleeding as result of medical issues, hormonal treatments, or surgical procedures were excluded.

2.5 Statistical analysis

All statistical analyses in this study were conducted using dietary weights, ensuring precision and integrity in line with the least common denominator strategy guided by NHANES sampling weights (28). Continuous data were presented as mean values with standard deviations (SD), while categorical data were presented as counts (n) and proportions (%). To compare the baseline characteristics between the PID and non-PID groups, we employed the Mann–Whitney U test or t-test for continuous variables, and the chi-square test or Fisher’s exact test for categorical variables.

To elucidate the relationship between dietary magnesium intake and PID, weighted multivariable logistic regression analyses were conducted. Initially, magnesium intake was evaluated as a continuous variable and then divided into quartiles for detailed analysis: Q1 (below 133.12 mg/day), Q2 (133.12–214.93 mg/day), Q3 (214.93–287.19 mg/day), and Q4 (above 287.19 mg/day), with Q1 serving as the baseline comparison group. We tested different models (Models 1–3) by progressively adjusting for various risk factors. Model 1 remained unadjusted, Model 2 adjusted for key confounders including age and race, and Model 3 further adjusted for education level, marital status, PIR, BMI, regularity of menstrual periods, smoking status, and presence of chronic conditions including diabetes and hypertension. After converting dietary magnesium intake from a continuous to a categorical variable, trend tests were conducted to examine the linear relationship trend between dietary magnesium consumption and PID. Restricted cubic splines (RCS) were utilized to evaluate the nonlinear and dose–response relationships between the intake of dietary magnesium and PID. Additionally, stratified analyses and the inclusion of interaction terms were employed to examine the consistency of this association across different demographic groups. Multiple imputation (MI) is a method for addressing missing data by creating multiple datasets (29). The MI program uses the chained equations method to impute missing values for various variables, including education, PIR, BMI, and diabetes.

The association between magnesium intake and PID is expressed through odds ratios (ORs). Analyses were performed with R (version 4.2) and EmpowerStats (version 5.0). A two-sided p-value below 0.05 was considered statistically significant.

3 Results

3.1 Baseline characteristics of the participants

Table 1 presents the weighted demographic and baseline characteristics of the study participants. This study included 3,034 participants, with an average age of 40.01 years. The majority were Non-Hispanic White, with a high school education or higher, and either married or living with a partner. Compared to participants without PID, those diagnosed with PID were older, more likely to smoke and experience irregular menstrual cycles, had lower family income, higher BMI, and lower dietary magnesium intake levels (229.60 mg/day, p < 0.001) (Figure 2).

Table 1

Table 1. Characteristics of the women participants, weighted.

Figure 2

Figure 2. Dietary magnesium intake levels in participants with or without PID.

3.2 The associations between dietary magnesium intake and PID

Table 2 illustrates the association between dietary magnesium intake and the risk of developing PID. When dietary magnesium was treated as a continuous variable, a significant correlation was observed across all three models (Models I–III). Specifically, for each 1 mg/day increment in dietary magnesium intake, there was a notable reduction in PID risk, with odds ratios (OR) of 0.996 (0.994–0.998), 0.996 (0.994–0.999), and 0.997 (0.995–1.000) in Models I, II, and III, respectively. These findings suggest a robust relationship between higher dietary magnesium consumption and a reduced incidence of PID.

Table 2

Table 2. Weighted multivariable logistic regression to assess the association of magnesium intake with PID.

Additionally, when categorizing dietary magnesium intake into quartiles, the fully adjusted model (Model III) revealed that compared to individuals in the lowest quartile Q1 (less than 133.12 mg/day), the adjusted ORs for participants in Q2 (133.12–214.93 mg/day), Q3 (214.93–287.19 mg/day), and Q4 (more than 287.19 mg/day) were 0.480 (95% CI: 0.281–0.821, p = 0.012), 0.639 (95% CI: 0.323–1.265, p = 0.175), and 0.395 (95% CI: 0.177–0.879, p = 0.027), respectively (Table 2). Trend analysis showed that the likelihood of PID decreased by 23.4% with each quartile increase in dietary magnesium intake (adjusted OR = 0.766, 95%CI: 0.605–0.968, p = 0.046).

3.3 Restricted cubic spline curve fitting

Restricted cubic spline (RCS) plots were employed to visualize the correlation between dietary magnesium intake and PID. Figure 3A elucidates the non-adjusted dose–response curve between dietary magnesium intake and PID, while Figures 3B,C show the RCS curve adjusted for covariates, similar to Model II and Model III, respectively. These findings demonstrate a gradual decline in the incidence of PID with higher dietary magnesium intake. Overall, there is a linear negative relationship between dietary magnesium intake and PID, with the relationship being particularly pronounced in Subfigure C (P for non-linearity = 0.865).

Figure 3

Figure 3. RCS curve fit between dietary magnesium intake and PID. Solid lines represent smooth curve fits between variables. Shaded bands represent 95% confidence intervals from the fit. (A) No adjustment for covariates. (B) Adjusted for age, and race. (C) Adjusted for age, race, education level, marital status, poverty income ratio, body mass index, hypertension, diabetes, smoke and regular period. PID, Pelvic Inflammatory Disease; OR, odds ratio; CI, confidence interval.

3.4 Subgroup analyses

To further explore the potential link between the intake of dietary magnesium and PID, stratified analysis was performed for various subgroups within Model III (Figure 4). The analysis revealed a significant negative correlation between dietary magnesium consumption and PID among several subgroups. Specifically, elderly women, individuals with lower to middle household incomes, those with normal weight or overweight, non-smokers, individuals without diabetes, and those experiencing irregular menstrual cycles all showed a notable inverse relationship between dietary magnesium intake and PID (all p-values < 0.05). Of particular interest, the analysis identified a statistically significant interaction effect with age (interaction p-value = 0.023), indicating that the impact of age on this association is nuanced and warrants further investigation. To elucidate this interaction, we depicted the age-dependent relationship between dietary magnesium intake and PID using stratified smoothing curves in Figure 5. These curves provide a visual representation of how the relationship between dietary magnesium intake and PID varies across different age groups, offering deeper insights into the underlying dynamics of this association.

Figure 4

Figure 4. Stratified analyses of the association between dietary magnesium intake and PID according to baseline characteristics. The p value for interaction represents the likelihood of interaction be-tween the variable and PID. PIR, Poverty Income Ratio; BMI, Body Mass Index; PID, Pelvic Inflammatory Disease; OR, odds ratio; CI, confidence interval.

Figure 5

Figure 5. The association between dietary magnesium intake and PID stratified by age. Each stratification adjusted for all the factors (race, education, marital status, body mass index, poverty income ratio, smoke, diabetes, hypertension and regular period). PID, Pelvic Inflammatory Disease; OR, odds ratio; CI, confidence interval.

4 Discussion

To our knowledge, this is the first study to utilize multivariate logistic regression analysis to investigate the relationship between dietary magnesium intake and the risk of developing PID. In this cross-sectional study with 3,034 participants, we found that higher dietary magnesium intake significantly reduced the likelihood of developing PID. Specifically, compared to the lowest quartile (Q1), participants in the highest quartile (Q4) had a 60.5% lower risk of PID (p = 0.027). This negative correlation remained significant even after adjusting for potential confounding variables. Subgroup analysis revealed a significant interaction effect of age on the relationship between dietary magnesium intake and PID. These findings suggest that increasing dietary magnesium intake may be a promising strategy for reducing the incidence of PID.

Previous research have explored the associations between various vitamins and minerals and PID. For example, a previous study in Zimbabwe demonstrated that a single dose of 400,000 IU vitamin A administration at less than 96 h postpartum significantly reduced the risk of late-term reproductive tract infections, consequently decreasing the number of PID-related medical visits among HIV-positive women (30). Besides, Çekmez and his colleagues found that women with PID exhibited considerably higher levels of serum Vitamin D than their non-PID counterparts (31). Additionally, Hu’s study found a significant correlation between reduced dietary copper intake and a lower incidence of PID (4). Our study uniquely highlights a negative association between dietary magnesium intake and PID risk, providing a novel perspective and detailed analysis not clearly established in prior research.

Recent human studies have indicated that magnesium supplementation can significantly reduce various inflammatory markers, particularly C-reactive protein (CRP) (32, 33). Lower CRP levels have been associated with effective management and control of PID (34). These findings suggest that increasing dietary magnesium intake may play a preventative role against PID infections. Furthermore, magnesium supplements have been shown to effectively alleviate pelvic pain symptoms (35, 36), underscoring their therapeutic potential in the treatment of PID. Given the existing evidence, our findings are biologically plausible and introduce a new dimension to the understanding of dietary magnesium’s role in PID prevention and management.

The precise mechanism linking dietary magnesium intake and PID remains incompletely elucidated, with potential mechanisms including immune modulation and reduction of oxidative stress. Studies have indicated that magnesium exhibits inhibitory effects on inflammatory responses and interacts with the immune system, thereby enhancing both innate and adaptive immunity (37). PID commonly arises from microbial infections such as Chlamydia trachomatis and Neisseria gonorrhoeae, and the subsequent immune responses (38). Given the pivotal role of magnesium in sustaining a robust immune system, increasing dietary magnesium intake could bolster immune responses, potentially reducing the risk of developing PID. Furthermore, oxidative stress is considered a contributing factor to chronic PID (39). PID diminishes the activity of superoxide dismutase (SOD) while increasing malondialdehyde (MDA) levels (40). Interestingly, increased dietary magnesium intake has been demonstrated to lower MDA levels, effectively mitigating oxidative stress (41, 42). Conversely, inadequate magnesium intake has been identified as a cause of oxidative stress. Therefore, enhancing dietary magnesium intake may mitigate oxidative stress by reducing MDA levels, consequently lowering the risk of pelvic inflammatory disease.

In this study, the effect of dietary magnesium intake on the risk of PID varied by age. Stratified analysis revealed a significant inverse association between dietary magnesium intake and PID in older adults, whereas no such association was observed in younger adults. Our finding aligns with a prior study that demonstrated a significant inverse relationship between dietary magnesium intake and anemia, particularly among the elderly population (age > 60 years) (43). Several factors may explain this age-related difference. Biologically, older adults may have a diminished ability to absorb and retain magnesium due to age-related changes in digestive and kidney functions. As individuals age, their digestive efficiency declines, impairing magnesium absorption (44), while the kidneys’ capacity to regulate magnesium weakens, resulting in increased excretion (45). Additionally, older adults may have different dietary patterns and lifestyle factors compared to younger individuals, which can influence magnesium intake and absorption. For example, older adults are more likely to consume magnesium-rich foods or supplements due to increased health awareness or medical advice (46). Furthermore, the prevalence of chronic conditions that benefit from magnesium intake is higher among older individuals, making the effects of dietary magnesium more pronounced in this age group (44). Therefore, ensuring an adequate supply of magnesium is particularly important for older adults.

Our findings hold significant implications for clinical practice, research, and health policymaking. To our knowledge, antibiotics are the mainstay of PID treatment (47, 48). However, the surge in antibiotic resistance underscores the urgent need for alternative preventive and treatment strategies. Our study suggests that increased dietary magnesium intake could serve as a non-pharmacological prevention method. For at-risk women, it is recommended to meet the daily magnesium intake of 300 mg, as advised by the NIH. This can be achieved by consuming magnesium-rich foods such as a handful of dry roasted almonds (80 mg), half a cup of cooked spinach (78 mg), and half a cup of black beans (60 mg). Ensuring adequate magnesium intake may help lower PID risk.

The study has several strengths. Based on the comprehensive NHANES database, encompassing a vast population sample and incorporating appropriate NHANES sample weights, our analysis enhances the representativeness of our results. Additionally, rigorous adjustment for confounding covariates in our model ensures the reliability and wider applicability of our findings. However, several limitations of this study deserve attention. Firstly, due to its cross-sectional design, the causal effect of magnesium on PID cannot be determined. Secondly, questionnaires and other measures introduce a latent information bias in assessing dietary magnesium intake and PID prevalence. Thirdly, data from NHANES is the only source of the study, which may restrict the study’s generalizability. Further research is needed to establish the causal relationship between dietary magnesium intake and PID, as well as to investigate optimal intake levels of magnesium, considering individual variability and dietary patterns.

5 Conclusion

This study provides evidence that higher dietary magnesium intake may be protective against PID, particularly in older individuals. These findings highlight the significant role of dietary factors in gynecological health and suggest that magnesium supplementation may be a valuable strategy in PID prevention. However, due to the cross-sectional design and the presence of potential confounding factors, these results should be interpreted with caution. Further longitudinal and interventional studies are needed to confirm causality and explore biological mechanisms. It is also crucial to delve into the optimal levels of magnesium intake and how they interact with other dietary components and lifestyle factors, in order to formulate optimal prevention strategies.

Data availability statement

Our research is based on public data from the NHANES; all details are from the official website (https://www.cdc.gov/nchs/nhanes/index.htm). To obtain the application executable files, please contact the author Zeru Chen by email: zrchan007@126.com.

Author contributions

ZC: Conceptualization, Data curation, Formal analysis, Methodology, Software, Visualization, Writing – original draft, Writing – review & editing. ZW: Data curation, Investigation, Writing – original draft. YZ: Conceptualization, Methodology, Resources, Supervision, Funding acquisition, Writing – review & editing.

Funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Shenzhen Science and Technology Innovation grant (No. JCYJ20220531091200001, No.JCYJ20210324123005014), the Natural Science Foundation of Guangdong Province (2023A1515010425), and the Innovation Research Grant of Shenzhen Longhua District (10162A20230325EBBE4EA).

Acknowledgments

Thanks to Zhang Jing (Second Department of Infectious Disease, Shanghai Fifth People’s Hospital, Fudan University) for his work on the NHANES database. His outstanding work, nhanesR package and webpage, makes it easier for us to explore NHANES database. We express our sincere gratitude to all the patients and clinical researchers who were involved in the included studies for their wonderful work and valuable participation.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Curry, A, Williams, T, and Penny, ML. Pelvic inflammatory disease: diagnosis, management, and prevention. Am Fam Physician. (2019) 100:357–64.

PubMed Abstract | Google Scholar

2. Kaambo, E, Africa, C, Chambuso, R, and Passmore, JS. Vaginal microbiomes associated with aerobic vaginitis and bacterial vaginosis. Front Public Health. (2018) 6:78. doi: 10.3389/fpubh.2018.00078

PubMed Abstract | Crossref Full Text | Google Scholar

3. Sesti, F, Capozzolo, T, Pietropolli, A, Collalti, M, Bollea, MR, and Piccione, E. Dietary therapy: a new strategy for Management of Chronic Pelvic Pain. Nutr Res Rev. (2011) 24:31–8. doi: 10.1017/s0954422410000272

Crossref Full Text | Google Scholar

4. Hu, P, Zhang, S, Li, H, Yan, X, Zhang, X, and Zhang, Q. Association between dietary trace minerals and pelvic inflammatory disease: data from the 2015-2018 National Health and nutrition examination surveys. Front Nutr. (2023) 10:1273509. doi: 10.3389/fnut.2023.1273509

PubMed Abstract | Crossref Full Text | Google Scholar

5. Garrison, SR, Korownyk, CS, Kolber, MR, Allan, GM, Musini, VM, Sekhon, RK, et al. Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev. (2020) 2020:Cd009402. doi: 10.1002/14651858.CD009402.pub3

Crossref Full Text | Google Scholar

6. Gröber, U, Schmidt, J, and Kisters, K. Magnesium in prevention and therapy. Nutrients. (2015) 7:8199–226. doi: 10.3390/nu7095388

PubMed Abstract | Crossref Full Text | Google Scholar

7. Sakaguchi, Y, Hamano, T, and Isaka, Y. Effects of magnesium on the phosphate toxicity in chronic kidney disease: time for intervention studies. Nutrients. (2017) 9:112. doi: 10.3390/nu9020112

PubMed Abstract | Crossref Full Text | Google Scholar

8. Tarleton, EK . Factors influencing magnesium consumption among adults in the United States. Nutr Rev. (2018) 76:526–38. Epub 2018/06/08. doi: 10.1093/nutrit/nuy002

Crossref Full Text | Google Scholar

9. Ford, ES, and Mokdad, AH. Dietary magnesium intake in a National Sample of us adults. J Nutr. (2003) 133:2879–82. doi: 10.1093/jn/133.9.2879

Crossref Full Text | Google Scholar

10. Song, Y, Ridker, PM, Manson, JE, Cook, NR, Buring, JE, and Liu, S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. (2005) 28:1438–44. doi: 10.2337/diacare.28.6.1438

PubMed Abstract | Crossref Full Text | Google Scholar

11. de Baaij, JH, Hoenderop, JG, and Bindels, RJ. Magnesium in man: implications for health and disease. Physiol Rev. (2015) 95:1–46. doi: 10.1152/physrev.00012.2014

PubMed Abstract | Crossref Full Text | Google Scholar

12. Dibaba, DT, Xun, P, and He, K. Dietary magnesium intake is inversely associated with serum C-reactive protein levels: Meta-analysis and systematic review. Eur J Clin Nutr. (2015) 69:409. doi: 10.1038/ejcn.2014.275

PubMed Abstract | Crossref Full Text | Google Scholar

13. King, DE, Mainous, AG 3rd, Geesey, ME, and Ellis, T. Magnesium intake and serum C-reactive protein levels in children. Magnes Res. (2007) 20:32–6.

PubMed Abstract | Google Scholar

14. Song, Y, Li, TY, van Dam, RM, Manson, JE, and Hu, FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr. (2007) 85:1068–74. doi: 10.1093/ajcn/85.4.1068

PubMed Abstract | Crossref Full Text | Google Scholar

15. von Elm, E, Altman, DG, Egger, M, Pocock, SJ, Gøtzsche, PC, and Vandenbroucke, JP. The strengthening the reporting of observational studies in epidemiology (Strobe) statement: guidelines for reporting observational studies. Lancet. (2007) 370:1453–7. doi: 10.1016/s0140-6736(07)61602-x

Crossref Full Text | Google Scholar

16. Wu, Z, Ruan, Z, Liang, G, Wang, X, Wu, J, and Wang, B. Association between dietary magnesium intake and peripheral arterial disease: results from Nhanes 1999-2004. PLoS One. (2023) 18:e0289973. doi: 10.1371/journal.pone.0289973

PubMed Abstract | Crossref Full Text | Google Scholar

17. Du, W, Yan, C, Wang, Y, Song, C, Li, Y, Tian, Z, et al. Association between dietary magnesium intake and gallstones: the mediating role of Atherogenic index of plasma. Lipids Health Dis. (2024) 23:82. doi: 10.1186/s12944-024-02074-4

PubMed Abstract | Crossref Full Text | Google Scholar

18. Lin, ZF, Lin, HW, Liao, WZ, Huang, ZM, Liao, XY, Wang, YY, et al. The association between dietary magnesium intake with chronic obstructive pulmonary disease and lung function in us population: a cross-sectional study. Biol Trace Elem Res. (2024) 202:3062–72. doi: 10.1007/s12011-024-04073-z

PubMed Abstract | Crossref Full Text | Google Scholar

19. Liu, H, Wang, D, Wu, F, Dong, Z, and Yu, S. Association between inflammatory potential of diet and self-reported severe headache or migraine: a cross-sectional study of the National Health and nutrition examination survey. Nutrition. (2023) 113:112098. doi: 10.1016/j.nut.2023.112098

PubMed Abstract | Crossref Full Text | Google Scholar

20. Zhang, Y, Liu, W, Zhang, W, Cheng, R, Tan, A, Shen, S, et al. Association between blood Lead levels and Hyperlipidemiais: results from the Nhanes (1999-2018). Front Public Health. (2022) 10:981749. doi: 10.3389/fpubh.2022.981749

PubMed Abstract | Crossref Full Text | Google Scholar

21. Mac Lean, RR, Cowan, A, and Vernarelli, JA. More to gain: dietary energy density is related to smoking status in us adults. BMC Public Health. (2018) 18:365. doi: 10.1186/s12889-018-5248-5

PubMed Abstract | Crossref Full Text | Google Scholar

22. Kim, K, Song, Y, Oh, TJ, Choi, SH, and Jang, HC. Association between Iron intake and diabetic peripheral neuropathy in type 2 diabetes: significance of Iron intake and the ratio between Iron intake and polyunsaturated fatty acids intake. Nutrients. (2020) 12:3365. doi: 10.3390/nu12113365

Crossref Full Text | Google Scholar

23. Zhang, K, Han, Y, Gu, Z, Hou, Z, Yu, X, Gao, M, et al. Association between dietary vitamin E intake and cognitive decline among old American: National Health and nutrition examination survey. Eur Geriatr Med. (2023) 14:1027–36. doi: 10.1007/s41999-023-00814-w

PubMed Abstract | Crossref Full Text | Google Scholar

24. Grundy, SM, Stone, NJ, Bailey, AL, Beam, C, Birtcher, KK, Blumenthal, RS, et al. 2018 Aha/Acc/Aacvpr/Aapa/Abc/Acpm/Ada/Ags/Apha/Aspc/Nla/Pcna guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. Circulation. (2019) 139:e1082–143. doi: 10.1161/cir.0000000000000625

PubMed Abstract | Crossref Full Text | Google Scholar

25. Fan, Y, Zhang, C, and Bu, J. Relationship between selected serum metallic elements and obesity in children and adolescent in the U.S. Nutrients. (2017) 9:104. doi: 10.3390/nu9020104

Crossref Full Text | Google Scholar

26. Li, XY, Wen, MZ, Liu, H, Shen, YC, Su, LX, and Yang, XT. Dietary magnesium intake is protective in patients with periodontitis. Front Nutr. (2022) 9:976518. doi: 10.3389/fnut.2022.976518

PubMed Abstract | Crossref Full Text | Google Scholar

27. Hastie, CE, Padmanabhan, S, Slack, R, Pell, AC, Oldroyd, KG, Flapan, AD, et al. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. (2010) 31:222–6. doi: 10.1093/eurheartj/ehp317

PubMed Abstract | Crossref Full Text | Google Scholar

28. Johnson, CL, Paulose-Ram, R, Ogden, CL, Carroll, MD, Kruszon-Moran, D, Dohrmann, SM, et al. National Health and nutrition examination survey: analytic guidelines, 1999-2010. Vital Health Stat. (2013)2:1–24.

Google Scholar

29. Patrician, PA . Multiple imputation for missing data. Res Nurs Health. (2002) 25:76–84. doi: 10.1002/nur.10015

Crossref Full Text | Google Scholar

30. Zvandasara, P, Hargrove, JW, Ntozini, R, Chidawanyika, H, Mutasa, K, Iliff, PJ, et al. Mortality and morbidity among postpartum Hiv-positive and Hiv-negative women in Zimbabwe: risk factors, causes, and impact of single-dose postpartum vitamin a supplementation. J Acquir Immune Defic Syndr. (2006) 43:107–16. doi: 10.1097/01.qai.0000229015.77569.c7

Crossref Full Text | Google Scholar

31. Çekmez, Y, Öcal, D, Korkmaz, V, Sertoğlu, E, Uçar, Y, and Küçüközkan, T. The diagnostic role of vitamin D and cathelicidin levels in pelvic inflammatory disease. Clin Lab. (2015) 61:1871–5. Epub 2016/02/18.

PubMed Abstract | Google Scholar

32. Veronese, N, Pizzol, D, Smith, L, Dominguez, LJ, and Barbagallo, M. Effect of magnesium supplementation on inflammatory parameters: a meta-analysis of randomized controlled trials. Nutrients. (2022) 14:679. doi: 10.3390/nu14030679

PubMed Abstract | Crossref Full Text | Google Scholar

33. Shokrpour, M, and Asemi, Z. The effects of magnesium and vitamin E co-supplementation on hormonal status and biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome. Biol Trace Elem Res. (2019) 191:54–60. doi: 10.1007/s12011-018-1602-9

Crossref Full Text | Google Scholar

34. Reljic, M, and Gorisek, B. C-reactive protein and the treatment of pelvic inflammatory disease. Int J Gynaecol Obstet. (1998) 60:143–50. doi: 10.1016/s0020-7292(97)00236-1

Crossref Full Text | Google Scholar

35. Gök, S, and Gök, B. Investigation of laboratory and clinical features of primary dysmenorrhea: comparison of magnesium and Oral contraceptives in treatment. Cureus. (2022) 14:e32028. doi: 10.7759/cureus.32028

PubMed Abstract | Crossref Full Text | Google Scholar

36. Parente, E, Colannino, G, Bilotta, G, Espinola, MSB, Proietti, S, Oliva, MM, et al. Effect of Oral high molecular weight hyaluronic acid (Hmwha), alpha lipoic acid (ala), magnesium, vitamin B6 and vitamin D supplementation in pregnant women: a retrospective observational pilot study. Clin Pract. (2023) 13:1123–9. doi: 10.3390/clinpract13050100

PubMed Abstract | Crossref Full Text | Google Scholar

37. Tam, M, Gómez, S, González-Gross, M, and Marcos, A. Possible roles of magnesium on the immune system. Eur J Clin Nutr. (2003) 57:1193–7. doi: 10.1038/sj.ejcn.1601689

Crossref Full Text | Google Scholar

38. Darville, T . Pelvic inflammatory disease due to Neisseria gonorrhoeae and Chlamydia Trachomatis: immune evasion mechanisms and pathogenic disease pathways. J Infect Dis. (2021) 224:S39–s46. doi: 10.1093/infdis/jiab031

PubMed Abstract | Crossref Full Text | Google Scholar

39. Amini, L, Chekini, R, Nateghi, MR, Haghani, H, Jamialahmadi, T, Sathyapalan, T, et al. The effect of combined vitamin C and vitamin E supplementation on oxidative stress markers in women with endometriosis: a randomized, triple-blind placebo-controlled clinical trial. Pain Res Manag. (2021) 2021:5529741–6. doi: 10.1155/2021/5529741

PubMed Abstract | Crossref Full Text | Google Scholar

40. Kong, D, Fu, P, Zhang, Q, Ma, X, and Jiang, P. Protective effects of Asiatic acid against pelvic inflammatory disease in rats. Exp Ther Med. (2019) 17:4687–92. doi: 10.3892/etm.2019.7498

PubMed Abstract | Crossref Full Text | Google Scholar

41. Orhan, C, Er, B, Deeh, PBD, Bilgic, AA, Ojalvo, SP, Komorowski, JR, et al. Different sources of dietary magnesium supplementation reduces oxidative stress by regulation Nrf2 and Nf-Κb signaling pathways in high-fat diet rats. Biol Trace Elem Res. (2021) 199:4162–70. doi: 10.1007/s12011-020-02526-9

PubMed Abstract | Crossref Full Text | Google Scholar

42. Bo, S, and Pisu, E. Role of dietary magnesium in cardiovascular disease prevention, insulin sensitivity and diabetes. Curr Opin Lipidol. (2008) 19:50–6. doi: 10.1097/MOL.0b013e3282f33ccc

Crossref Full Text | Google Scholar

43. Huang, J, Xu, J, Ye, P, and Xin, X. Association between magnesium intake and the risk of Anemia among adults in the United States. Front Nutr. (2023) 10:1046749. doi: 10.3389/fnut.2023.1046749

PubMed Abstract | Crossref Full Text | Google Scholar

44. Mountokalakis, TD . Effects of aging, chronic disease, and multiple supplements on magnesium requirements. Magnesium. (1987) 6:5–11.

PubMed Abstract | Google Scholar

45. Musso, CG, Juarez, R, Vilas, M, Navarro, M, Rivera, H, and Jauregui, R. Renal calcium, phosphorus, magnesium and uric acid handling: comparison between stage iii chronic kidney disease patients and healthy oldest old. Int Urol Nephrol. (2012) 44:1559–62. doi: 10.1007/s11255-012-0230-0

PubMed Abstract | Crossref Full Text | Google Scholar

46. Gacek, M . Energy and nutrients content in planned for consumption dietary rations of old People's home dwellers in Cracov. Rocz Panstw Zakl Hig. (2010) 61:207–12.

PubMed Abstract | Google Scholar

47. Yusuf, H, and Trent, M. Management of pelvic inflammatory disease in clinical practice. Ther Clin Risk Manag. (2023) 19:183–92. doi: 10.2147/tcrm.S350750

PubMed Abstract | Crossref Full Text | Google Scholar

48. Jennings, LK, and Krywko, DM. Pelvic inflammatory disease In: Statpearls. Treasure Island, FL: StatPearls Publishing (2024)

Google Scholar